Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y L Han

Showing results (21-30 of 148) with videos related to

Pageof 15
Sort By:
Zhonghua Xin Xue Guan Bing Za Zhi|December 16, 2025
[Interpretation of the 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the management of patients with acute coronary syndromes]Y Li, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|August 31, 2017
[Development of percutaneous coronary intervention in China]Y L Han, Y Li
Zhonghua Xin Xue Guan Bing Za Zhi|August 28, 2020
[Pharmaco-invasive therapy is an effective reperfusion strategy for ST-segment elevation myocardial infarction]Y L Han, Y Li
Zhonghua Xin Xue Guan Bing Za Zhi|December 15, 2021
[Progress in optimizing antiplatelet therapy after percutaneous coronary intervention in the year of 2021]Y L Han, Y Li
Zhonghua Xin Xue Guan Bing Za Zhi|June 21, 2026
[Optimized antithrombotic therapy for coronary artery disease: current status and future perspectives]Y Li, Y L Han
Zhonghua Yi Xue Za Zhi|June 25, 2023
[Transcatheter interventional therapy for heart valve disease: applications and challenges]K Xu, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|July 14, 2021
[History and development of percutaneous coronary intervention for coronary heart disease in China]Y L Han, Y Li
Zhonghua Xin Xue Guan Bing Za Zhi|April 21, 2025
[Transcatheter atrioventricular valve intervention therapy: opportunities and challenges]K Xu, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|March 2, 2019
[Current situation of ST-segment elevation myocardial infarction rescue in China and optimal management strategies we can use today]B He, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|May 19, 2022
[Path of exploration for the optimal antithrombotic treatment strategy for patients with coronary heart disease]Y Li, Y L Han
Pageof 15

Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
Zhonghua Xin Xue Guan Bing Za Zhi|December 16, 2025
[Interpretation of the 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the management of patients with acute coronary syndromes]Y Li, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|August 31, 2017
[Development of percutaneous coronary intervention in China]Y L Han, Y Li
Zhonghua Xin Xue Guan Bing Za Zhi|August 28, 2020
[Pharmaco-invasive therapy is an effective reperfusion strategy for ST-segment elevation myocardial infarction]Y L Han, Y Li
Zhonghua Xin Xue Guan Bing Za Zhi|December 15, 2021
[Progress in optimizing antiplatelet therapy after percutaneous coronary intervention in the year of 2021]Y L Han, Y Li
Zhonghua Xin Xue Guan Bing Za Zhi|June 21, 2026
[Optimized antithrombotic therapy for coronary artery disease: current status and future perspectives]Y Li, Y L Han
Zhonghua Yi Xue Za Zhi|June 25, 2023
[Transcatheter interventional therapy for heart valve disease: applications and challenges]K Xu, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|July 14, 2021
[History and development of percutaneous coronary intervention for coronary heart disease in China]Y L Han, Y Li
Zhonghua Xin Xue Guan Bing Za Zhi|April 21, 2025
[Transcatheter atrioventricular valve intervention therapy: opportunities and challenges]K Xu, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|March 2, 2019
[Current situation of ST-segment elevation myocardial infarction rescue in China and optimal management strategies we can use today]B He, Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|May 19, 2022
[Path of exploration for the optimal antithrombotic treatment strategy for patients with coronary heart disease]Y Li, Y L Han
Pageof 15